Follow
Flavio Andres Salazar Onfray
Flavio Andres Salazar Onfray
Other namesFlavio Salazar-Onfray
Profesor de Inmunología, Universidad de Chile
Verified email at uchile.cl - Homepage
Title
Cited by
Cited by
Year
Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated …
K Kono, F Salazar‐Onfray, M Petersson, J Hansson, G Masucci, ...
European journal of immunology 26 (6), 1308-1313, 1996
4241996
Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression.
M Matsuda, F Salazar, M Petersson, G Masucci, J Hansson, P Pisa, ...
The Journal of experimental medicine 180 (6), 2371-2376, 1994
4171994
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas
Y Rongcun, F Salazar-Onfray, J Charo, KJ Malmberg, K Evrin, H Maes, ...
The Journal of Immunology 163 (2), 1037-1044, 1999
2461999
Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape
F Salazar-Onfray, MN López, A Mendoza-Naranjo
Cytokine & growth factor reviews 18 (1-2), 171-182, 2007
2282007
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor …
MN López, C Pereda, G Segal, L Munoz, R Aguilera, FE González, ...
J Clin Oncol 27 (6), 945-952, 2009
1972009
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
A Escobar, M Lopez, A Serrano, M Ramirez, C Pérez, A Aguirre, ...
Clinical & Experimental Immunology 142 (3), 555-568, 2005
1602005
Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in …
M Petersson, J Charo, F Salazar-Onfray, G Noffz, M Mohaupt, Z Qin, ...
The Journal of Immunology 161 (5), 2099-2105, 1998
1601998
Tumor cell lysates as immunogenic sources for cancer vaccine design
FE González, A Gleisner, F Falcón-Beas, F Osorio, MN López, ...
Human vaccines & immunotherapeutics 10 (11), 3261-3269, 2014
1592014
Interleukin-10: a cytokine used by tumors to escape immunosurveillance
F Salazar-Onfray
Medical oncology 16 (2), 86-94, 1999
1521999
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
I Poschke, Y Mao, L Adamson, F Salazar-Onfray, G Masucci, R Kiessling
Cancer Immunology, Immunotherapy 61, 827-838, 2012
1502012
Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker
F Salazar-Onfray, M Lopez, A Lundqvist, A Aguirre, A Escobar, A Serrano, ...
British journal of cancer 87 (4), 414-422, 2002
1472002
Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells
A Mendoza-Naranjo, PJ Saéz, CC Johansson, M Ramírez, D Mandakovic, ...
The Journal of Immunology 178 (11), 6949-6957, 2007
1162007
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
F Salazar-Onfray, J Charo, M Petersson, S Freland, G Noffz, Z Qin, ...
Journal of immunology (Baltimore, Md.: 1950) 159 (7), 3195-3202, 1997
1161997
A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and transporter associated with antigen processing 1/2 in human …
M Kurte, M López, A Aguirre, A Escobar, JC Aguillón, J Charo, CG Larsen, ...
The Journal of Immunology 173 (3), 1731-1737, 2004
1112004
Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells
R Aguilera, C Saffie, A Tittarelli, FE González, M Ramírez, D Reyes, ...
Clinical Cancer Research 17 (8), 2474-2483, 2011
1072011
Tumour necrosis factor (TNF) α− 308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis
M Cuchacovich, L Soto, M Edwardes, M Gutierrez, C Llanos, D Pacheco, ...
Scandinavian journal of rheumatology 35 (6), 435-440, 2006
1042006
Tumour necrosis factor‐α (TNF‐α) levels and influence of− 308 TNF‐α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis
M Cuchacovich, L Ferreira, M Aliste, L Soto, J Cuenca, A Cruzat, H Gatica, ...
Scandinavian journal of rheumatology 33 (4), 228-232, 2004
1022004
Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation
A Mendoza-Naranjo, G Bouma, C Pereda, M Ramírez, KF Webb, ...
The Journal of Immunology 187 (6), 3121-3132, 2011
942011
Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases
JP Mackern-Oberti, C Llanos, F Vega, F Salazar-Onfray, CA Riedel, ...
Autoimmunity reviews 14 (2), 127-139, 2015
932015
The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific
SM Bueno, PA González, LJ Carreño, JA Tobar, GC Mora, CJ Pereda, ...
Immunology 124 (4), 522-533, 2008
932008
The system can't perform the operation now. Try again later.
Articles 1–20